Dr. Vivek P. Buch, MD

Dr. Buch practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Buch's NPI, 1821352337, was assigned on June 28, 2012. Dr. Buch graduated from The Warren Alpert Medical School of Brown University in 2013. Dr. Buch's California license number on file is A167057.

Dr. Buch's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Buch's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Buch to 1 more hospital and 2 medical groups, each named with a free account. Dr. Buch's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buch practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Buch's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Buch is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Buch's licenses on file in 6 states: California, Nevada, Alaska, Hawaii, Oregon and Pennsylvania.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, lower back pain and thoracic spine disorders among the conditions Dr. Buch treats.

CMS data shows 86 Medicare services from Dr. Buch across 4 procedure codes in 2024, for 90 Medicare patients. Medicare paid $58,908 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 90 Medicare patients who saw Dr. Buch in 2024. The largest group is 65 to 74, with 36 patients. 71% of them have high cholesterol, and 66% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Buch's median patient age at 57, with 44% women.

In 2024, Dr. Buch wrote 16 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. They cover 2 drugs, with $554 in total drug cost. In 2022, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Buch for performance year 2024, reported as part of a group. Dr. Buch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buch as offering telehealth.

Dmand AI links 58 papers to Dr. Buch, published from 2015 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Brain, Electroencephalography and Deep Brain Stimulation. Dr. Buch has published most often in World Neurosurg. Dr. Buch's most frequent co-authors are Josef Parvizi, MD, PhD, Ashwin Gurijala Ramayya, MD, PhD and Peter John Madsen, MD.

CMS Open Payments shows 246 general payments to Dr. Buch from 8 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Boston Scientific Corporation paid the most, $48,051.

Dr. Buch graduated from The Warren Alpert Medical School of Brown University in 2013. Dr. Buch is a member of CNS.

Dr. Buch is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.